相关实验视频

Updated: Jun 5, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

在抗TNF治疗的类风湿性关节炎患者中,NADPH氧化酶表达特征和PBMC免疫表型变化

Tomasz Wysocki¹, Anna Wajda¹, Tomasz Kmiołek¹

¹National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.

Clinical immunology (Orlando, Fla.)

|December 6, 2024

概括

这项研究发现NOX2基因表达与类风湿性关节炎 (RA) 治疗反应之间没有联系. 然而,它揭示了在RA患者中NCF1基因表达和单细胞标记物CD14之间的新鲜联系.

科学领域:

免疫学免疫学免疫学
遗传学遗传学是一个
类风湿病学类风湿病学

背景情况:

类风湿性关节炎 (RA) 是一种自身免疫性疾病,其特征是慢性炎症.
NOX2基因表达特征在RA病原和治疗反应中的作用需要进一步研究.
周围血液单核细胞 (PBMCs) 在免疫反应和疾病进展中至关重要.

研究的目的:

预期评估PBMC中NOX2基因表达特征 (NCF1,NCF2,NCF4) 对RA患者免疫特征的影响.
评估NOX2基因表达与RA的临床特征之间的关联.
确定抗TNF治疗对NOX2基因表达的影响及其与治疗反应的相关性.

主要方法:

对31名RA患者和25名健康对照进行前性评估.
在PBMC中分析NCF1,NCF2,NCF4和CD14的mRNA表达水平.
测量免疫调节性细胞因子度.
在抗TNF治疗期间对16名RA患者的随访.

主要成果:

与健康对照组相比,在RA患者中观察到NCF4和CD14表达的显著上调.
在RA患者和健康对照中发现NCF1和CD14mRNA水平之间的正相关性.
NOX2基因表达特征与抗TNF反应或RA临床特征没有相关性.
反TNF治疗没有影响NOX2基因表达.

结论:

该研究发现了NCF1基因表达与单细胞分化抗原CD14之间的新联系.
在PBMC中NOX2基因表达特征并不是RA中抗TNF治疗反应的预测因素.
需要进一步的研究来阐明在RA中NCF1-CD14关联的功能影响.

关键词:

抗TNFα剂的使用.氧二氧化 (NOX2) 是一种病理机制是一种病理机制.药物基因组学药物基因组学类风湿性关节炎类风湿性关节炎类风湿性关节炎

更多相关视频

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method

Published on: September 16, 2017

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...